Literature DB >> 18637876

Pacemaker/defibrillator evaluation at Los Angeles County Department of Coroner*.

Pauline Saint-Martin1, Christopher Rogers, Joseph Muto, Noel G Boyle, Daniel Rieders, Lakshmanan Sathyavagiswaran.   

Abstract

Pacemakers and implantable cardioverter-defibrillators (ICDs) are implanted medical devices for the treatment of cardiac arrhythmias. These devices are now commonly encountered in the postmortem situation. The Los Angeles County Department of the Coroner uses the services of a cardiac electrophysiology consultant to interrogate pacemakers and ICDs, producing a detailed picture of the cardiac events recorded by the device. We have used this method to evaluate 20 cases where the ICD or pacemaker provided significant information. We report four forensic cases to illustrate the different applications of pacemaker interrogation and its contribution in forensic investigation. This technique was used to establish identification of the decedent, to determine the cause and time of death, and to determine whether device malfunction could have played a role in the death. We conclude that detailed evaluation of the pacemaker or ICD in selected cases may provide essential information to the forensic pathologist.

Entities:  

Mesh:

Year:  2008        PMID: 18637876     DOI: 10.1111/j.1556-4029.2008.00805.x

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  3 in total

1.  Pacemaker failure as a cause of sudden death.

Authors:  Daniel P Morin
Journal:  Virchows Arch       Date:  2017-10-27       Impact factor: 4.064

2.  Cardiac conduction devices in the radiologic comparative identification of decedents.

Authors:  Vasiliki Chatzaraki; Garyfalia Ampanozi; Michael J Thali; Wolf Schweitzer
Journal:  Forensic Sci Med Pathol       Date:  2019-11-14       Impact factor: 2.007

Review 3.  An approach to iatrogenic deaths.

Authors:  Angela R McGuire; Maura E DeJoseph; James R Gill
Journal:  Forensic Sci Med Pathol       Date:  2016-01-28       Impact factor: 2.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.